Clinical and economic burden of pneumococcal disease in older US adults.
作者： Derek Weycker , David Strutton , John Edelsberg , Reiko Sato , Lisa A. Jackson
DOI: 10.1016/J.VACCINE.2010.05.030
关键词:
摘要: We developed a model characterizing rates and costs of pneumococcal disease in the US to estimate expected annual clinical economic burden this condition among older adults. Among 91.5 million adults aged >or=50 years, 29,500 cases invasive disease, 502,600 nonbacteremic pneumonia, 25,400 pneumococcal-related deaths are estimated occur yearly; direct indirect total $3.7 billion $1.8 billion, respectively. Pneumococcal remains substantial adults, despite increased coverage with PPV23 benefits afforded by PCV7 vaccination young children.
cabdirect.org
elsevier.com
sci-hub.se 参考文章(30)
VLADIMIR KAPLAN, DEREK C. ANGUS, MARTIN F. GRIFFIN, GILLES CLERMONT, R. SCOTT WATSON, WALTER T. LINDE-ZWIRBLE, Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. American Journal of Respiratory and Critical Care Medicine. ,vol. 165, pp. 766- 772 ,(2002) , 10.1164/AJRCCM.165.6.2103038
F. Lagerström, M. Bader, M. Foldevi, H. Fredlund, I. Nordin-Olsson, H. Holmberg, Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Örebro, Sweden Clinical Microbiology and Infection. ,vol. 9, pp. 645- 652 ,(2003) , 10.1046/J.1469-0691.2003.00602.X
Barbara J. Marston, Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. JAMA Internal Medicine. ,vol. 157, pp. 1709- 1718 ,(1997) , 10.1001/ARCHINTE.1997.00440360129015
G.W. WATERER, R.G. WUNDERINK, The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures Respiratory Medicine. ,vol. 95, pp. 78- 82 ,(2001) , 10.1053/RMED.2000.0977
L.S.G.E. Howard, M. Sillis, M.C. Pasteur, A.V. Kamath, B.D.W. Harrison, Microbiological profile of community-acquired pneumonia in adults over the last 20 years. Journal of Infection. ,vol. 50, pp. 107- 113 ,(2005) , 10.1016/J.JINF.2004.05.003
Atsushi Saito, Shigeru Kohno, Toshiharu Matsushima, Akira Watanabe, Kotaro Oizumi, Keizo Yamaguchi, Hiroshi Oda, Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan Journal of Infection and Chemotherapy. ,vol. 12, pp. 63- 69 ,(2006) , 10.1007/S10156-005-0425-8
Milton C. Weinstein, Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. ,vol. 276, pp. 1253- 1258 ,(1996) , 10.1001/JAMA.1996.03540150055031
Agustı́n Ruiz-González, Miguel Falguera, Antoni Nogués, Manuel Rubio-Caballero, Is Streptococcus Pneumoniae the leading cause of pneumonia of unknown etiology? a microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia The American Journal of Medicine. ,vol. 106, pp. 385- 390 ,(1999) , 10.1016/S0002-9343(99)00050-9
Miquel Falguera, Oscar Sacristán, Antoni Nogués, Agustín Ruiz-González, Mercè García, Anton Manonelles, Manuel Rubio-Caballero, Nonsevere Community-Acquired Pneumonia: Correlation Between Cause and Severity or Comorbidity JAMA Internal Medicine. ,vol. 161, pp. 1866- 1872 ,(2001) , 10.1001/ARCHINTE.161.15.1866
Jennifer C. Nelson, Michael Jackson, Onchee Yu, Cynthia G. Whitney, Lora Bounds, Rachel Bittner, Ann Zavitkovsky, Lisa A. Jackson, Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine. ,vol. 26, pp. 4947- 4954 ,(2008) , 10.1016/J.VACCINE.2008.07.016